Author

Judith L. White

Observed names: JUDITH L. WHITE, Judith L White, Judith White

OpenAlex ID: A5110781087

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

2017 · Paresh Dandona, Chantal Mathieu, et al. · The Lancet Diabetes & Endocrinology · 297

PDF

Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

2021 · Erika A. Petersen, Thomas G. Stauss, et al. · JAMA Neurology · 288

PDF

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

2018 · Paresh Dandona, Chantal Mathieu, et al. · Diabetes Care · 245

Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial

2023 · Erika A. Petersen, Thomas G. Stauss, et al. · Diabetes Research and Clinical Practice · 57

PDF

Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial

2021 · Erika A. Petersen, Thomas G. Stauss, et al. · Diabetes Care · 49

High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial

2022 · Erika A. Petersen, Thomas G. Stauss, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 34

PDF

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

2014 · Judith L White, Patricia Buchanan, et al. · BMC Endocrine Disorders · 21

PDF

High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy

2024 · Erika A. Petersen, Thomas G. Stauss, et al. · Journal of Diabetes Science and Technology · 14

PDF

Long‐term efficacy of 10 kHz spinal cord stimulation in managing painful diabetic neuropathy: A post‐study survey

2025 · Erika A. Petersen, Shawn M. Sills, et al. · Pain Practice · 9

PDF

Health care resource utilization and costs in patients with painful diabetic neuropathy treated with 10 kHz spinal cord stimulation therapy

2023 · Rod S. Taylor, Shivanand P. Lad, et al. · Journal of Managed Care & Specialty Pharmacy · 8

PDF

22-LB: 24-Month Results for 10-kHz Spinal Cord Stimulation (SCS) in Treating Painful Diabetic Neuropathy (PDN)

2022 · ERIKA PETERSEN, THOMAS G. STAUSS, et al. · Diabetes · 2

10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy - A Multicenter Randomized Controlled Trial

2020 · Erika A Petersen, Thomas Stauss, et al. · Neurosurgery · 2

From Reliving to Relieving

2014 · Judith L. White · Journal of Humanistic Psychology · 2

P158 Quality-of-life and Hba1c Continue to Improve at 4 Years Post-implant in Patients With Painful Diabetic Neuropathy Treated With 10khz Spinal Cord Stimulation

2025 · Erika Petersen, Shawn Sills, et al. · Neuromodulation Technology at the Neural Interface · 1

Abstract #1184813: Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy: 18-Month Multicenter Randomized Controlled Trial Results

2022 · Erika Petersen, Thomas Stauss, et al. · Endocrine Practice · 1

31-LB: Neuromodulation for Treatment of Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial

2020 · ERIKA PETERSEN, THOMAS STAUSS, et al. · Diabetes · 1

16-LB: Long-Term 10 kHz Spinal Cord Stimulation in Painful Diabetic Neuropathy: A Randomized Controlled Trial

2021 · ERIKA PETERSEN, JAMES SCOWCROFT, et al. · Diabetes

Abstract #1003782: Neuromodulation for Treatment of Painful Diabetic Neuropathy - Sustained Benefits of 10kHz Spinal Cord Stimulation in a Randomized Controlled Trial

2021 · Erika A. Petersen, Thomas G. Stauss, et al. · Endocrine Practice

Works count: 18

Citation count: 1,031

H-index: 9

I10-index: 8